Not Tagged
gilead sciences
['$gild']
dr meisel also says that while os is "nice to see, pfs is what really makes the difference" for these metastatic patients. will the fda agree? $gild #asco22
Pharma and biotech reporter, found a home at Evaluate Vantage.